Slug Is Increased in Vascular Remodeling and Induces a Smooth Muscle Cell Proliferative Phenotype

PLoS One. 2016 Jul 21;11(7):e0159460. doi: 10.1371/journal.pone.0159460. eCollection 2016.

Abstract

Objective: Previous studies have confirmed Slug as a key player in regulating phenotypic changes in several cell models, however, its role in smooth muscle cells (SMC) has never been assessed. The purpose of this study was to evaluate the expression of Slug during the phenotypic switch of SMC in vitro and throughout the development of vascular remodeling.

Methods and results: Slug expression was decreased during both cell-to-cell contact and TGFβ1 induced SMC differentiation. Tumor necrosis factor-α (TNFα), a known inductor of a proliferative/dedifferentiated SMC phenotype, induces the expression of Slug in SMC. Slug knockdown blocked TNFα-induced SMC phenotypic change and significantly reduced both SMC proliferation and migration, while its overexpression blocked the TGFβ1-induced SMC differentiation and induced proliferation and migration. Genome-wide transcriptomic analysis showed that in SMC, Slug knockdown induced changes mainly in genes related to proliferation and migration, indicating that Slug controls these processes in SMC. Notably, Slug expression was significantly up-regulated in lungs of mice using a model of pulmonary hypertension-related vascular remodeling. Highly remodeled human pulmonary arteries also showed an increase of Slug expression compared to less remodeled arteries.

Conclusions: Slug emerges as a key transcription factor driving SMC towards a proliferative phenotype. The increased Slug expression observed in vivo in highly remodeled arteries of mice and human suggests a role of Slug in the pathogenesis of pulmonary vascular diseases.

MeSH terms

  • Animals
  • Cell Dedifferentiation / drug effects
  • Cell Dedifferentiation / genetics
  • Cell Movement / drug effects
  • Cell Movement / genetics
  • Cell Proliferation / drug effects
  • Cell Proliferation / genetics
  • Disease Models, Animal
  • Female
  • Gene Expression Regulation / drug effects
  • Humans
  • Hypertension, Pulmonary / genetics
  • Hypertension, Pulmonary / pathology
  • Lung / metabolism
  • Lung / pathology
  • Mice, Inbred C57BL
  • Models, Biological
  • Myocytes, Smooth Muscle / cytology*
  • Myocytes, Smooth Muscle / metabolism*
  • Phenotype
  • Pulmonary Artery / pathology
  • Snail Family Transcription Factors / genetics
  • Snail Family Transcription Factors / metabolism*
  • Transforming Growth Factor beta1 / pharmacology
  • Tumor Necrosis Factor-alpha / pharmacology
  • Vascular Remodeling* / drug effects
  • Vascular Remodeling* / genetics

Substances

  • Snail Family Transcription Factors
  • Transforming Growth Factor beta1
  • Tumor Necrosis Factor-alpha

Grants and funding

This work was supported by the Instituto de Salud Carlos III (ISCIII), grants FIS PI13/0083 to VIP and FIS PS09/00536 to JAB, and the Sociedad Española de Pneumologia y Cirugía Toracica (SEPAR), grant SEPAR-2009 to MMM. MMM is recipient of a Sara Borrell contract from ISCIII. JGL is recipient of a Pre-doctoral contract from the ISCIII. MVP is recipient of a Post-doctoral contract from CONICET. This work was also funded by the Fundación Contra la Hipertensión Pulmonar (FCHP). "Cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER). Unión Europea. Una manera de hacer Europa". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.